Show simple item record

dc.contributor.authorBaşer, Onur
dc.contributor.authorKariburyo, M. Furaha
dc.contributor.authorDu, J
dc.contributor.authorXie, L
dc.date.accessioned2019-02-28T13:04:26Z
dc.date.accessioned2019-02-28T11:08:14Z
dc.date.available2019-02-28T13:04:26Z
dc.date.available2019-02-28T11:08:14Z
dc.date.issued2015en_US
dc.identifier.citationBaser, O., Kariburyo, MF., Du, J., & Xie, L. (2015). Comparing healthcare resource utilization and costs among schizophrenic patients who initiated typical vs. Atypical long-acting injectables in the us veteran population. Value in Health. 18, 3, p. 119.en_US
dc.identifier.issn1098-3015
dc.identifier.issn1524-4733
dc.identifier.urihttp://dx.doi.org/10.1016/j.jval.2015.03.698
dc.identifier.urihttps://hdl.handle.net/20.500.11779/622
dc.descriptionOnur Başer (MEF Author)en_US
dc.description.abstractOBJECTIVES: To evaluate healthcare resource utilization and costs among schizophrenic patients who initiated typical and atypical long-acting injectables (LAIs) inthe U.S. veteran population. METHODS: Using the Veterans Health Administration(VHA) Medical SAS datasets, patients with ?1 pharmacy claim for LAIs were identified from 01OCT2005 through 30SEPT2012. The first LAI date was designated asthe index date. Patients were required to be age ?18 years, have continuous healthplan enrollment for 12 months pre-index date and a schizophrenia diagnosis(International Classification of Diseases, 9th Revision, Clinical Modification [ICD9-CM] code 295.xx) during the study period. Patient data was observed until theearlier date of death or the end of the study period, and patients were assigned totypical LAI (fluphenazine, haloperidol, perphenazine) or atypical LAI (aripiprazole,olanzapine, paliperidone, risperidone) antipsychotic cohorts. All-cause (follow-up)and psychiatric disorder-related healthcare resource utilization and costs wereassessed. Follow-up health care costs were adjusted to per-patient-per-month.The generalized linear model (GLM) was used to assess cost and utilization differences among the cohorts. RESULTS: A total of 4,796 patients were identified(Typical LAI cohort: N=1,941; Atypical LAI cohort: N=2,855). Typical LAI patientswere older (age 53.81 vs. 50.94 years, p<0.0001) and more likely to be black (34.47%vs. 28.27%, p<0.0001) than atypical LAI patients. After adjusting for baseline differences using GLM, more patients prescribed typical LAIs had all-cause emergencyroom [ER] visits (61.66% vs. 58.11%, p=0.024) and inpatient stays (63.11% vs. 59.00%, p=0.008) and psychiatric disorder-related ER visits (33.83% vs. 30.05%, p=0.011)than those prescribed atypical LAIs. However, typical LAI patients incurred lowerall-cause pharmacy ($197 vs. $433, p<0.001), total ($2,850 vs. $3,073, p=0.048) andpsychiatric disorder-related total costs ($1,615 vs. $1,624, p=0.908) than atypical LAIpatients. CONCLUSIONS: Although patients who initiated typical LAIs had highhealthcare resource utilization, their economic burden was lower compared to thosewho initiated atypical LAIs.en_US
dc.language.isoengen_US
dc.relation.ispartofValue in Healthen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.titlePMH26 - comparing healthcare resource utilization and costs among schizophrenic patients who initiated typical vs. atypical long-acting injectables in the us veteran populationen_US
dc.typeMeeting Abstracten_US
dc.departmentİİSBF, Ekonomi Bölümüen_US
dc.identifier.volume18en_US
dc.identifier.issue3en_US
dc.identifier.startpage119en_US
dc.identifier.endpage119en_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.description.wosidWOS:000354498502041en_US
dc.contributor.institutionauthorBaşer, Onur
dc.description.woscitationindexScience Citation Index Expanded - Social Sciences Citation Indexen_US
dc.identifier.wosqualityQ1en_US
dc.description.WoSDocumentTypeMeeting Abstracten_US
dc.description.WoSInternationalCollaborationUluslararası işbirliği ile yapılan - EVETen_US
dc.description.WoSPublishedMonthMayısen_US
dc.description.WoSIndexDate2015en_US
dc.description.WoSYOKperiodYÖK - 2014-15en_US
dc.identifier.doi10.1016/j.jval.2015.03.698en_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record